In the search for the signaling pathways through which ERα leads to moesin activation in breast cancer cells, we used different pharmacological inhibitors linked to ERα or moesin to treat estrogen-receptor positive breast cancer cells. The gene discussed is ESR1; the disease is breast carcinoma.